DGAP-News: MediClin AG / Key word(s): Interim Report
MediClin AG: Group sales of the first nine months of FY 2012 increased
by 4.4 percent

01.11.2012 / 08:30

---------------------------------------------------------------------

Offenburg, 01 November 2012 - In the first nine months of FY 2012 MEDICLIN
Aktiengesellschaft (MediClin) has achieved Group sales of EUR 383.8 mill.
(9 M 2011: EUR 367.7 mill.) which were EUR 16.1 mill. or 4.4 % higher than
in the same period of last year. EUR 13.6 mill. of the sales increase were
attributed to the post-acute segment. Sales of the acute segment were EUR
150.8 mill. (9 M 2011: EUR150.7 mill.) thus on previous year's level, sales
of the business field nursing care increased by EUR 1.0 mill. up to EUR 9.8
mill. (9 M 2011: EUR 8.8 mill.).

The Group operating result of EUR 6.2 mill. (9 M 2011: EUR 7.0 mill.) was
EUR 0.8 mill. lower than in the same period of last year. The previous
year's value contained aperiodic releases of provisions in the amount of
EUR 2.9 mill. Adjusted by these special effects the Group operating result
for the first nine months of FY 2012 would be EUR 2.0 mill. higher than the
previous year's value.

Less other operating income in the amount of EUR 3.1 mill. as well as
additional expenses in the amount of in total EUR 13.8 mill. stood against
the increase in sales of EUR 16.1. mill. Of the additional expenses EUR 9.0
mill. applied to staff costs, EUR 3.4 mill to other operating expenses, EUR
0,8 mill. to raw materials and consumables used and EUR 0.7 mill. to
depreciation and amortisation.

The Group result attributable to shareholders of MediClin amounted to EUR
2.4 mill. (9 M 2011: EUR 0.6 mill.). The un-/diluted earnings per share for
the first nine months of FY 2012 amounted to EUR 0.05 (9 M 2011: EUR 0.01).

Post-acute segment clearly above previous year's figures 

The post-acute segment result of EUR 4.6 mill. has improved significantly
in the nine-month comparison. The determining factors were the noticeable
sales increase of EUR 13.6 mill. and an only under-proportional increase in
expenses.

For the same period with sales nearly unchanged and despite increased
numbers of nursing days and cases the acute segment result shows a decrease
of EUR 5.9 mill. Especially the 4.8 % higher staff costs as well as the 8.5
% higher other operating expenses - here in particular maintenance costs -
did burden the result.

Investments are still on a high level
In the reporting period, investments in non-current assets were made
totalling a gross amount of EUR 19.8 mill. (9 M 2011: EUR 24.0 mill.). As
of 30 September 2012 cash and cash equivalents were EUR 27.5 mill.
(31.12.2011: EUR 41.3 mill.). The equity ratio was 51.9 %

Outlook
The Management Board expects sales to rise and earnings to develop soundly
in the financial year 2012 provided there are no fundamental changes to the
conditions underlying the industry and to the referral behaviour of the
coverage providers.

The interim report as of 30 September 2012 will be available as of 14
November 2012 under www.mediclin.de in German and English.

/

About MediClin AG (Ticker: MED; WKN: 659 510) 
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungs-zentren (medical care units) in 11 federal states MediClin has
a total capacity of approximately 8,100 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,400 employees.


End of Corporate News

---------------------------------------------------------------------

01.11.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                               
Company:     MediClin AG                                           
             Okenstraße 27                                         
             77652 Offenburg                                       
             Germany                                               
Phone:       +49 (0)781 488-189                                    
Fax:         +49 (0)781 488-184                                    
E-mail:      alexandra.muehr@mediclin.de                           
Internet:    www.mediclin.de                                       
ISIN:        DE0006595101                                          
WKN:         659510                                                
Listed:      Regulierter Markt in Frankfurt (Prime Standard);      
             Freiverkehr in Berlin, Düsseldorf, Hamburg, München,  
             Stuttgart                                             
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
191120 01.11.2012